Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
International Journal of MS Care|November 3, 2016
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' ExperiencesFreya Davies, Fiona Wood, Katherine E Brain, et al.
International Ophthalmology|October 13, 2016
Alemtuzumab-induced remission of multiple sclerosis-associated uveitisMark D Willis, Trevor P Pickersgill, Neil P Robertson, et al.
Seizure|October 15, 2013
Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010W Owen Pickrell, Arron S Lacey, Rhys H Thomas, et al.
Epilepsy & Behavior : E&B|June 19, 2014
A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsyRhys H Thomas, Jordana Walsh, Carla Church, et al.
Multiple Sclerosis and Related Disorders|May 1, 2020
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohortEmma C Tallantyre, Daniel Castle, Paul Karamura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2019
Cerebrospinal fluid complement system biomarkers in demyelinating diseaseWioleta Milena Zelek, Dina Fathalla, Angharad Morgan, et al.
Neurology|February 22, 2022
COVID-19-Related Outcomes in Primary Mitochondrial Diseases: An International StudyChiara Pizzamiglio, Pedro M Machado, Rhys H Thomas, et al.
Human Mutation|April 23, 2022
Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discoveryDavid Lewis-Smith, Shridhar Parthasarathy, Julie Xian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2018
Sarcoidosis following alemtuzumab treatment for multiple sclerosisMark D Willis, Ben Hope-Gill, Patrick Flood-Page, et al.
Neurology|December 18, 2012
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosisMark D Cossburn, Katharine Harding, Gillian Ingram, et al.
Pageof 18